Matches in Nanopublications for { ?s ?p "[Human MTC-TT cells were treated with the PI3K inhibitor LY294002 (0-60 micromol/L) for 8 days, and cellular growth was measured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP585942.RADP-NW7zuWK3x3CwcMGj0mTBgB61xpOweEy37YLke5Xs130_assertion description "[Human MTC-TT cells were treated with the PI3K inhibitor LY294002 (0-60 micromol/L) for 8 days, and cellular growth was measured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585942.RADP-NW7zuWK3x3CwcMGj0mTBgB61xpOweEy37YLke5Xs130_provenance.
- NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_assertion description "[Human MTC-TT cells were treated with the PI3K inhibitor LY294002 (0-60 micromol/L) for 8 days, and cellular growth was measured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585950.RACDZM6WAYjxYvi4nbS8BN8bWTabGuomH-a7c1iSbBmXc130_provenance.
- NP585940.RApM2RYyTQoWeirXHP8l2RWp1yua4vZIY49ANJ43QStNs130_assertion description "[Human MTC-TT cells were treated with the PI3K inhibitor LY294002 (0-60 micromol/L) for 8 days, and cellular growth was measured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585940.RApM2RYyTQoWeirXHP8l2RWp1yua4vZIY49ANJ43QStNs130_provenance.
- NP585941.RAt_4_d1MTCt7sguhdzmH3_rwjOejd3v26DhCjJpE_A-w130_assertion description "[Human MTC-TT cells were treated with the PI3K inhibitor LY294002 (0-60 micromol/L) for 8 days, and cellular growth was measured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585941.RAt_4_d1MTCt7sguhdzmH3_rwjOejd3v26DhCjJpE_A-w130_provenance.
- NP585943.RAkJhDIiOt6GlL9ihZ6_KWYr6mxXSaVyHXwwq8m1IluH4130_assertion description "[Human MTC-TT cells were treated with the PI3K inhibitor LY294002 (0-60 micromol/L) for 8 days, and cellular growth was measured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585943.RAkJhDIiOt6GlL9ihZ6_KWYr6mxXSaVyHXwwq8m1IluH4130_provenance.
- NP585939.RA3NX8mEBb8ravhY0NFbJwASuuGtv7hkosVJ3iI1Bar78130_assertion description "[Human MTC-TT cells were treated with the PI3K inhibitor LY294002 (0-60 micromol/L) for 8 days, and cellular growth was measured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585939.RA3NX8mEBb8ravhY0NFbJwASuuGtv7hkosVJ3iI1Bar78130_provenance.
- NP585945.RAzHOsJMo6jR1J1DSt00xeInI9APZyYg_nrMSyPRPDK6c130_assertion description "[Human MTC-TT cells were treated with the PI3K inhibitor LY294002 (0-60 micromol/L) for 8 days, and cellular growth was measured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585945.RAzHOsJMo6jR1J1DSt00xeInI9APZyYg_nrMSyPRPDK6c130_provenance.
- NP585946.RA8Go15n6SRTAfPidtFUzDG7ECgAn9c7EymyuY323HdiI130_assertion description "[Human MTC-TT cells were treated with the PI3K inhibitor LY294002 (0-60 micromol/L) for 8 days, and cellular growth was measured.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585946.RA8Go15n6SRTAfPidtFUzDG7ECgAn9c7EymyuY323HdiI130_provenance.